Table 2.

Organ involvement of primary problem.

	CMV-positive patients (n = 85)	CMV-negative patients (n = 387)	p value
Interstitial lung disease, n (%)	30 (35.3%)	62 (16.0%)	< 0.0001
Nephritis, n (%)	20 (23.5%)	45 (11.6%)	0.0005
Arthritis, n (%)	16 (18.8%)	187 (48.3%)	< 0.0001
Peripheral nerve disorders, n (%)	10 (11.8%)	22 (5.7%)	0.0070
Rash, n (%)	8 (9.4%)	34 (8.8%)	0.1013
Myositis, n (%)	7 (8.2%)	28 (7.2%)	0.0965
Pancytopenia, n (%)	6 (7.1%)	16 (4.1%)	0.0412
Fever, n (%)	5 (5.9%)	11 (2.8%)	0.0272
Alveolar hemorrhage, n (%)	5 (5.9%)	3 (0.8%)	0.0001
Peripheral circulatory disorders, n (%)	4 (4.7%)	6 (1.6%)	0.0111
Pleuritis, n (%)	3 (3.5%)	22 (5.7%)	0.0660
Sore throat, n (%)	3 (3.5%)	6 (1.6%)	0.0380
Eosinophilia, n (%)	3 (3.5%)	6 (1.6%)	0.0380
Pericarditis, n (%)	3 (1.9%)	6 (1.6%)	0.0380
Pulmonary hypertension, n (%)	3 (3.5%)	1 (0.3%)	0.0004
Optic neuritis, n (%)	3 (3.5%)	0 (0.0%)	< 0.0001
Lymphadenopathy, n (%)	2 (2.4%)	7 (1.8%)	0.0959
Central nervous system lupus, n (%)	2 (2.4%)	4 (1.0%)	0.0530
Meningitis, n (%)	2 (2.4%)	4 (1.0%)	0.0530
Pneumocystis pneumounia, n (%)	2 (2.4%)	2 (0.5%)	0.0158
Genital ulcer, n (%)	2 (2.4%)	1 (0.3%)	0.0842
Gastrontestinal ulcer, n (%)	2 (2.4%)	1 (0.3%)	0.0043
Peritonitis, n (%)	2 (2.4%)	1 (0.3%)	0.0043
Myelitis, n (%)	2 (2.4%)	1 (0.3%)	0.0043
Epicarditis, n (%)	1 (1.2%)	1 (0.3%)	0.0398
Oral aphtha, n (%)	1 (1.2%)	7 (1.8%)	0.0921
Enteritis, n (%)	1 (1.2%)	3 (0.8%)	0.0944